Prospective Validation Study of a Novel Type IV Home Sleep Apnea Test

Last updated: March 19, 2019
Sponsor: Ectosense NV
Overall Status: Active - Recruiting

Phase

N/A

Condition

Sleep Disorders

Sleep Apnea Syndromes

Treatment

N/A

Clinical Study ID

NCT03385187
17/034U
  • Ages > 18
  • All Genders
  • Accepts Healthy Volunteers

Study Summary

Prospective validation study of the NightOwl, a Type IV home sleep apnea test (HSAT), compared to a traditional Type I and a Type IV sleep monitor.

Eligibility Criteria

Inclusion

Inclusion Criteria:

  • Indication for a sleep study

Exclusion

Exclusion Criteria:

  • Mentally disabled people

  • Known allergy to Plexiglas (PMMA) or other acrylates

Study Design

Total Participants: 450
Study Start date:
June 29, 2017
Estimated Completion Date:
December 15, 2019

Study Description

The purpose of this prospective validation study is the evaluation of the accuracy of the NightOwl HSAT to derive parameters relevant for the diagnosis of sleep apnea. The NightOwl HSAT comprises a finger or forehead mounted sensor and an automated analytics software. The sensor measures double-wavelength photo-plethysmography and accelerometry. The analytics software automatically interprets the sensor data and derives a measure of sympathetic activation of the autonomic nervous system, oxygen saturation, instantaneous pulse rate and activity. For each patient in the cohort, the AHI derived by the NightOwl will be compared to that of the Type I sleep monitor (in-lab PSG), which will acquire data simultaneously during the diagnostic night of the patient referred to the sleep lab for a polysomnography. On a randomly selected subset of patients, a Type IV sleep monitor will additionally be applied for comparison of its automated AHI derivation to that of the NightOwl.

Connect with a study center

  • Ziekenhuis Oost-Limburg

    Genk, Limburg 3600
    Belgium

    Active - Recruiting

Not the study for you?

Let us help you find the best match. Sign up as a volunteer and receive email notifications when clinical trials are posted in the medical category of interest to you.